Literature DB >> 24644388

SUZUKI-MIYAURA COUPLING REACTIONS OF 3,5-DICHLORO-1,2,4-THIADIAZOLE.

Abdelbasset A Farahat1, David W Boykin2.   

Abstract

3,5-Dichloro-1,2,4-thiadiazole was allowed to react with different arylboronic acids under different Suzuki-Miyaura coupling conditions: at room temperature 5-aryl-3-chloro-1,2,4-thiadiazoles were obtained and at toluene reflux temperature the products were 3,5-diaryl-1,2,4-thiadiazoles. Sequential coupling reactions lead to 3,5-diaryl-1,2,4-thiadiazoles with non-identical aryl groups. The structure of 3-methoxy-5-(4-methoxyphenyl)-1,2,4-thiadiazole was established from X-ray crystallographic data.

Entities:  

Year:  2012        PMID: 24644388      PMCID: PMC3955708          DOI: 10.3987/COM-12-12533

Source DB:  PubMed          Journal:  Heterocycles        ISSN: 0385-5414            Impact factor:   0.831


  18 in total

Review 1.  Advances in the synthesis and recent therapeutic applications of 1,2,4-thiadiazole heterocycles.

Authors:  Ana Castro; Tania Castaño; Arantxa Encinas; Williams Porcal; Carmen Gil
Journal:  Bioorg Med Chem       Date:  2005-10-24       Impact factor: 3.641

2.  Origin of regioselectivity in palladium-catalyzed cross-coupling reactions of polyhalogenated heterocycles.

Authors:  Claude Y Legault; Yeimy Garcia; Craig A Merlic; K N Houk
Journal:  J Am Chem Soc       Date:  2007-10-03       Impact factor: 15.419

3.  Facile synthesis of substituted 5-amino- and 3-amino-1,2,4-thiadiazoles from a common precursor.

Authors:  Paul M Wehn; Paul E Harrington; John E Eksterowicz
Journal:  Org Lett       Date:  2009-12-17       Impact factor: 6.005

4.  Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.

Authors:  Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2012-02-11       Impact factor: 3.641

5.  Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors.

Authors:  Timothy C Gahman; Mark R Herbert; Henk Lang; Angie Thayer; Kent T Symons; Phan Manh Nguyen; Mark E Massari; Sara Dozier; Yan Zhang; Marciano Sablad; Tadimeti S Rao; Stewart A Noble; Andrew K Shiau; Christian A Hassig
Journal:  Bioorg Med Chem Lett       Date:  2011-09-08       Impact factor: 2.823

6.  Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.

Authors:  Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2011-09-25       Impact factor: 3.641

7.  Synthesis and antiprotozoal activity of 2,5-bis[amidinoaryl]thiazoles.

Authors:  Danuta Branowska; Abdelbasset A Farahat; Arvind Kumar; Tanja Wenzler; Reto Brun; Yang Liu; W David Wilson; David W Boykin
Journal:  Bioorg Med Chem       Date:  2010-03-27       Impact factor: 3.641

Review 8.  Medicinal chemistry and properties of 1,2,4-thiadiazoles.

Authors:  Tim Fat Tam; Regis Leung-Toung; Wanren Li; Michael Spino; Khashayar Karimian
Journal:  Mini Rev Med Chem       Date:  2005-04       Impact factor: 3.862

9.  Iodoxolone-based hypervalent iodine reagents.

Authors:  Azhar-ul-Haq A Shah; Zulfiqar A Khan; Naila Choudhary; Christine Lohölter; Sascha Schäfer; Guillaume P L Marie; Umar Farooq; Bernhard Witulski; Thomas Wirth
Journal:  Org Lett       Date:  2009-08-20       Impact factor: 6.005

10.  Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group.

Authors:  Takashi Kondo; Takahiro Nekado; Isamu Sugimoto; Kenya Ochi; Shigeyuki Takai; Atsushi Kinoshita; Akira Hatayama; Susumu Yamamoto; Katsuya Kishikawa; Hisao Nakai; Masaaki Toda
Journal:  Bioorg Med Chem       Date:  2007-11-17       Impact factor: 3.641

View more
  1 in total

1.  Engineered modular heterocyclic-diamidines for sequence-specific recognition of mixed AT/GC base pairs at the DNA minor groove.

Authors:  Pu Guo; Abdelbasset A Farahat; Ananya Paul; David W Boykin; W David Wilson
Journal:  Chem Sci       Date:  2021-11-02       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.